Measles virus vaccine live inhaled - Serum Institute of India

Drug Profile

Measles virus vaccine live inhaled - Serum Institute of India

Alternative Names: Inhaled measles virus vaccine - Serum Institute of India/Aerogen

Latest Information Update: 22 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Serum Institute of India
  • Class Measles vaccines; Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Measles

Most Recent Events

  • 22 Mar 2017 No recent reports of development identified - Phase-III for Measles (In infants, Prevention) in India (Inhalation)
  • 03 May 2011 Phase-III clinical trials in Measles in India (Inhalation)
  • 01 Dec 2009 Phase-II/III clinical trials in Measles in India (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top